Pirfenidone: A Potential New Therapy for Restrictive Allograft Syndrome?
Open Access
- 1 November 2013
- journal article
- research article
- Published by Elsevier in American Journal of Transplantation
- Vol. 13 (11) , 3035-3040
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Bronchiolitis Obliterans Syndrome and Restrictive Allograft SyndromeTransplantation, 2013
- Pirfenidone: A potential therapy for progressive lung allograft dysfunction?The Journal of Heart and Lung Transplantation, 2013
- Restrictive allograft syndrome post lung transplantation is characterized by pleuroparenchymal fibroelastosisLaboratory Investigation, 2013
- Progression pattern of restrictive allograft syndrome after lung transplantationThe Journal of Heart and Lung Transplantation, 2013
- Into the matrixCurrent Opinion in Pulmonary Medicine, 2012
- Inhibitory Effects of Pirfenidone on Dendritic Cells and Lung Allograft RejectionTransplantation, 2012
- Survival Determinants in Lung Transplant Patients With Chronic Allograft DysfunctionTransplantation, 2011
- Restrictive allograft syndrome (RAS): A novel form of chronic lung allograft dysfunctionThe Journal of Heart and Lung Transplantation, 2011
- Treatment of Intractable Interstitial Lung Injury with Alemtuzumab after Lung TransplantationTransplantation Proceedings, 2011
- Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trialsThe Lancet, 2011